In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CooperSurgical Inc.

Division of Cooper Cos. Inc.
www.coopersurgical.com

Latest From CooperSurgical Inc.

ParaGard TV Spot Misrepresents Contraceptive’s Risks, US FDA Says

The agency took issue with distracting visuals and reliance on superimposed text in a television spot for CooperSurgical's copper-containing intrauterine device, which is regulated as a drug. This is the third untitled letter from the US FDA to target promotions for women’s health products in the past eighteen months.

Ad Complaints Medical Device

ParaGard TV Spot Misrepresents Contraceptive’s Risks, US FDA Says

‘Untitled’ letter is FDA's third in the past eighteen months to target promotions for women’s health products. In the case of advertisement for CooperSurgical's copper-containing intrauterine device, which is regulated as a drug, the agency took issue with distracting visuals and reliance on superimposed text.

Advertising, Marketing & Sales Ad Complaints

FDA Approves Channel Medystems’ Cerene Endometrial Cryotherapy

Cerene is indicated for endometrial cryoablation in premenopausal women. Channel's PMA is based on 12-month results from the CLARITY trial, which showed procedural success with Cerene in about 77% of patients.

Commercial Approvals

Market Intel: Let's Talk About It — The Rising Tide Of 'Femtech' Companies

Femtech, which describes digital technologies that aim to improve women's health, is expected to reach $50bn in market size by 2025, according to Frost & Sullivan. Reproductive health and menstrual health trackers are two of the fastest-growing sectors in femtech. We've highlighted some of the biggest players in both segments, their innovative business models, plans and also looked at barriers such as privacy issues, accuracy of mobile applications and funding challenges.

Market Intelligence Commercial
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register